StageZero Life Sciences Ltd T.SZLS

More consolidation in US health care

[davewho]

• UnitedHealth to buy Change Healthcare for $7.84 billion to build up technology services UnitedHealth Group has agreed to buy Change Healthcare for $7.84 billion in cash, the companies said, to beef up its portfolio of healthcare technology services.

• UnitedHealth Group Inc and Change Healthcare Inc: UnitedHealth Group has agreed to buy Change Healthcare for $7.84 billion in cash, the companies said, to beef up its portfolio of healthcare technology services. The health insurer will pay $25.75 per Change Healthcare share in cash, a premium of 41.2% to Tuesday's closing price. The acquisition is expected to add to UnitedHealth's adjusted earnings per share by about 50 cents in 2022. Change Healthcare's platform, which manages revenue, payment cycles and clinical information, and Optum's data analytics solutions will help simplify clinical, administrative and payment processes, the companies said.

[frewil11]

Let me guess Change Healthcare was bought out because they are working on early cancer detection through testing of a blood sample , but they won't be launching it to market for another 3 or 4 years , obviously I am just being sarcastic but how is Aristotle completely over looked and no one even knows it exists.   

[capebretongirl]

Fair point - when one googles liquid biopsy cancer detection there is really no mention of SZLS. I am posting an overview on this subject I just found on the net - includes Grail. Approved Liquid Biopsy Technologies Currently, the CELLSEARCH CTC kit (Menarini Silicon Biosystems, Inc.) is the only liquid biopsy test that has been approved by Health Canada (March 9, 2010).28 It is also the

[LithLover]

In the prospectus with the max offering they had indicated they would allocate $3 million to market Aristotle.  With the offering closed in the middle I expect they are setting aside approx $1.8 million.  They need a big splash and a decent size sales force. If this truly is 10+ years in the making Tripp better be coming out everywhere with some big announcements, partnerships and

[VerifiedUser123]

Two things: I don't understand how even 3 million would be appropriate to initiate a marketing launch Tripp's credibility has always been in question 

[capebretongirl]

As compared to what - would 0 million be preferable?

[VerifiedUser123]

Where is the marketing plan woman??  Look at how much it costs to throw a billboard up, radio, or a tv spot in a Georgia senate race! You think they give 'incompetent CEO' discounts. 

[capebretongirl]

[VerifiedUser123]

Shaking my head. You are so thick! 

[capebretongirl]

Keep shaking it - the senses will find their way back eventually.

[Jonnyboy85]

Not to mention to 70+ new partners we've signed for covid, you think they aren't getting the full Aristotle dossier with each and every covid contract? We don't even have to market at this point, we're about to launch at the height of our visibility. Lol veryfriedloser is going to pull a muscle reaching this hard, go get your diaper changed old man you stink

[VerifiedUser123]

I'll change the diaper if you go back to bashing your head against the wall. You mother really dropped the ball with you

[Jonnyboy85]

I'm sorry the loud loud music hurt your hearing aid;) the only person I ever heard use the phrase bash your head against the wall in reference to heavy metal was my 95 year old grandpa lol old man alert** no wonder you're so cranky all the time! You shouldn't be shorting with your retirement money but I get it, your junk doesn't work anymore so you gotta take it out on someone

[VerifiedUser123]

LOL

[Newfinvest]

This post has been removed in accordance with Community Policy

[MarketMoney]

  the 10000 test seem to be a minimum to show data after clinical trials, same thing with Thrive who tested 10000 women for clinical trial and then showed their data last year. Like any other bio company they will do further tests but in the meanwhile we are focusing in the launch of ARISTOTLE wich is essential to be a Leader in this field. Things are getting better and cashflow from

[StockscoutX]

Odds could be that StageZero will be bought by a biotech company that is listed on the Nasdaq or not before it applies to be listed on the Nasdaq.

[ThisIsYerChance]

Whoa could be totally caught off guard this is yer chance

[LithLover]

The cash set aside for marketing of Aristotle was indicated to be $600,000 with the minimum offering and $3 million with the maximum offering.  (page 33 of the November 26, 2020 final prospectus filed on Sedar)  The offering landed in the middle so should be around the $1.8 million mark.  Maybe more with the increased CoVid revenue.  

[frewil11]

It will not matter much if they launch it Q1 or not because if they don't market this properly and most important of all don't have the right partnerships in place .

[capebretongirl]

Recall that Clarus predicted an NR on affiliations prior to the launch of Aristotle - this would be of great importance as a springboard.  I know we have Ichor but it is on the small side - we need a large hosptial or medical network with US inroads. I am hopeful that such an affiliation is in the final stages of closing and that we hear something shortly. Based on the credibility of the

[VerifiedUser123]

Yeah, that's worrisome for sure! The big players are neither stupid or short of cash, if they even thought we'd either make it to market or that we had a half decent product they could easily buy us for pennies on the dollar.